Combining β-core fragment and total oestriol measurement to test for Down syndrome pregnancies

Prenatal Diagnosis

Volumn 17, Issue 12, 1997, Pages 1125-1133

  Cole, Laurence A ^a   Acuna, Edgar ^a   Isozaki, Taichi ^a   Palomaki, Glenn E ^b   Bahado Singh, Ray O ^a   Mahoney, Maurice O ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

Down syndrome; Human chorionic gonadotropin; Oestriol; Prenatal diagnosis; Screening; core fragment

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CREATININE; ESTRIOL;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DOWN SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; PRENATAL SCREENING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SECOND TRIMESTER PREGNANCY; TRISOMY; URINALYSIS; URINE LEVEL;

EID: 0031440174     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0223(199712)17:12<1125::aid-pd201>3.0.co;2-%23     Document Type: Article

References (24)

1. Birken, S., Armstrong, E.G., Kolks, M.A.G., Cole, L.A., Agosto, G.M., Krichevsky, A., Canfield, R.E. (1988). The structure of the human chorionic gonadotropin β-subunit core fragment from pregnancy urine, Endocrinology, 123, 572-583.
2. Bogart, M.H., Pandian, M.R., Jones, O.W. (1987). Abnormal maternal serum hCG levels in pregnancies with fetal chromosome abnormalities, Prenat. Diagn., 7, 623-630.
3. Canick, J.A., Knight, G.J., Palomaki, G.E., Haddow, J.E., Cuckle, H.S., Wald, N.J. (1988). Low second trimester maternal serum unconjugated oestriol in pregnancies with Down syndrome, Br. J. Obstet. Gynaecol., 13, 30-33.
4. Canick, J.A., Kellner, L.H., Saller, D.N., Jr, Palomaki, G.E., Walker, R.P., Osathanondh, R. (1995). Second trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy, Prenat. Diagn., 15, 752-759.
5. Cole, L.A., Kardana, A., Seifer, D.B., Bohler, H.C. (1994). Urine hCG β-subunit core fragment, a sensitive test for ectopic pregnancy, J. Clin. Endocrinol. Metab., 78, 497-499.
6. Cole, L.A., Kellner, L.H., Isozaki, T., Palomaki, G.E., Iles, R.K., Walker, R.P., Ozaki, M., Canick, J.A. (1997a). Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies, Prenat. Diagn., 17, 607-614.
7. Cole, L.A., Jacobs, M., Isozaki, T., Palomaki, G.E., Bahado-Singh, R.O., Mahoney, M.J. (1997b). Screening for Down syndrome using urine hCG free β-subunit in the second trimester of pregnancy, Prenat. Diagn., 17, in press.
8. Cuckle, H.S., Wald, N.J., Lindenbaum, R.H. (1984). Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet, 1, 926-929.
9. Cuckle, H.S., Iles, R.K., Chard, T. (1994). Urinary β-core human chorionic gonadotropin: a new approach to Down's syndrome screening, Prenat. Diagn., 14, 953-958.
10. Cuckle, H.S., Iles, R.K., Sehmi, I.H., Chard, T., Oakey, R.E., Davies, S., Ind, T. (1995). Urinary multiple marker screening for Down's syndrome, Prenat. Diagn., 15, 745-751.
11. Hayashi, M., Kozu, H. (1995). Maternal urinary β-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy, Prenat. Diagn., 15, 11-16.
12. Isozaki, T., Palomaki, G.E., Bahado-Singh, R.O., Cole, L.A. (1997). Screening for Down syndrome pregnancy using β-core fragment: prospective study, Prenat. Diagn., 17, 407-413.
13. Kellner, L.H., Canick, J.A., Palomaki, G.E., Saller, D.N., Lambert-Messerlian, G.M., Neuer, M., Osathanondh, R., Bombard, A.T. (1996). Urinary markers: a new approach to screening for Down syndrome in the second trimester. Am. J. Hum. Genet., 59, A41 (207).
14. Macri, J.N., Kasturi, R.V., Krantz, D.A., Cook, E.J., Moore, N.D., Young, J.A., Romero, K., Larsen, J.W., Jr. (1990). Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin. Am. J. Obstet. Gynecol., 163, 1248-1253.
15. Palomaki, G.E., Knight, G.J., McCarthy, J., Haddow, J.E., Eckfeldt, J.H. (1993). Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey. Am. J. Obstet. Gynecol., 169, 1558-1562.
16. Palomaki, G.E., Neveux, L.M., Haddow, J.E. (1995). Are DADs (discriminant aneuploidy detection) as good as MOMs (multiples of the median)?, Am. J. Obstet. Gynecol., 173, 1895-1897.
17. Royston, P., Thompson, S.G. (1992). Model based screening by risk with application to Down's syndrome screening, Stats. Med., 11, 257-268.
18. Ryall, R.G., Staples, A.J., Robertson, E.F., Pollard, A.S. (1992). Improved performance of prenatal screening program for Down syndrome incorporating serum free hCG β-subunit analyses, Prenat. Diagn., 12, 251-261.
19. Spencer, K., Coombes, E.J., Mallard, A.S., Milford-Ward, A. (1992). Free beta human choriogonadotrophin in Down syndrome screening: a multicentre study of its role compared with other biochemical markers, Ann. Clin. Biochem., 29, 506-518.
20. Spencer, K., Macri, J.N., Anderson, R.W., Aitken, D.A., Berry, E., Crossley, J.A., Wood, P.J., Coombes, E.J., Stroud, M., Worthington, D.J. (1993). Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial, Ann. Clin. Biochem., 30, 394-401.
21. Spencer, K., Aitken, D.A., Macri, J.N., Buchanan, P.D. (1996). Urine free beta hCG and beta core in pregnancies affected by Down's syndrome, Prenat. Diagn., 16, 605-613.
22. Wald, N.J., Cuckle, H.S., Densem, J.W. (1988). Maternal serum unconjugated estriol as an antenatal screening test for Down syndrome, Br. J. Obstet. Gynaecol., 95, 334-335.
23. Wald, N.J., Densem, J.W., Stone, R., Cheng, R. (1993). The use of free β-hCG in antenatal screening for Down's syndrome, Br. J. Obstet. Gynaecol., 100, 550-557.
24. Zeitune, M., Aitken, D.A., Crossley, J.A., Yates, J.R., Cooke, A., Ferguson-Smith, M.A. (1991). Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies, Prenat. Diagn., 11, 847-857.